Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
09/30/2025
09/30/2024
09/30/2023
09/30/2022
09/30/2021
Hasılat
21
21
24
23
18
22
Hasılat Artışı (YoY)
-13%
-13%
4%
28%
-18%
0%
Satınalma Maliyeti
23
24
27
25
17
15
Brüt Kâr
-1
-3
-3
-1
1
7
Satış, Genel ve İdari
0
0
0
0
0
0
Araştırma ve Geliştirme
--
--
--
--
--
--
İşletme Giderleri
2
0
1
0
0
0
Diğer Finansman Gelirleri (Giderleri)
-112
-112
193
--
--
--
Kâr Öncesi Gelir
-115
-115
190
52
-86
194
Kira Vergisi Gideri
--
--
--
--
--
--
Net Kâr
-115
-115
190
52
-86
194
Net Income Growth
Kâr Artışı
-161%
-161%
265%
-160%
-144%
67%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
41
41
41
41.35
41.36
41.34
Hisse Değişimi (Yıllık Üst Üste)
0%
0%
-1%
0%
0%
0%
EPS (Diluted)
-2.8
-2.8
4.63
1.27
-2.09
4.71
EPS Artışı
-161%
-160%
263%
-161%
-144%
67%
Öz sermaye akışı
88
88
78
--
55
33
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
-4.76%
-14.28%
-12.5%
-4.34%
5.55%
31.81%
Faaliyet Kâr Marjı
-9.52%
-9.52%
-12.5%
-8.69%
0%
27.27%
Kâr Marjı
-547.61%
-547.61%
791.66%
226.08%
-477.77%
881.81%
Özsermaye Karlılık Oranı
419.04%
419.04%
325%
--
305.55%
150%
EBITDA
--
--
--
--
--
--
EBITDA Marjinali
--
--
--
--
--
--
D&A EBITDA için
--
--
--
--
--
--
Faaliyet Kârı
-2
-2
-3
-2
0
6
Faaliyet Kâr Marjı
-9.52%
-9.52%
-12.5%
-8.69%
0%
27.27%
Verilen Vergi Oranı
--
--
--
--
--
--
Önemli İstatistikler
Önceki Kapanış
$19.09
Açılış fiyatı
$19.12
Günün Aralığı
$19.04 - $19.23
52 haftalık aralık
$15.14 - $21.3
İşlem hacmi
77.5K
Ort.Hacim
177.6K
EPS (TTM)
-2.80
Dividend yield
11.05%
Piyasa Değeri
$792.8M
THQ nedir?
abrdn Healthcare Opportunities Fund is a US-based company operating in industry. The company is headquartered in Philadelphia, Pennsylvania. The company went IPO on 2014-07-25. abrdn Healthcare Opportunities Fund (the Fund) is a non-diversified closed-end management investment company. The Fund's investment objective is to seek current income and long-term capital appreciation. The Fund invests primarily in equity and debt in securities of public and private United States (U.S.) and non-U.S. companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. The Fund will not invest more than 20%, as measured at the time of investment, in convertible securities. The Fund also invests in private companies and other restricted securities, including private investments in public equity and venture capital investments. The company invests in health care providers and services, pharmaceuticals, health care equipment and supplies, life sciences tools and services, biotechnology, and medical devices and diagnostics. The Fund's investment adviser is abrdn Inc.